pDCs within the tumor microenvironment inhibit the anti-tumor functions of CD8+ T cells and NK cells by releasing immunosuppressive cytokines (IL-10 and TGF-β) and promoting the proliferation of Tregs (67). This evidence concerns the gene CD8A and neoplasm.